Metro in takeover talks with Jean Coutu Group

By zaymalz malz
Share

It has been confirmed that the Quebec-based grocery chain retailer, Metro, and Canadian pharmacy retailer, Jean Coutu Group, are in advanced talks about a potential takeover.

The two companies have revealed that they have signed a non-binding letter of intent that lays out the terms of a potential deal, that would see Metro buy Jean Coutu for $4.5bn at $24.50 per share in a majority cash agreement.

The transaction is yet to complete, and would require approval from the regulatory authorities, but if it goes through then the move would strengthen Metro’s position as one of Canada’s key retailers. The grocery chain would acquire Jean Coutu’s 400 stores in Quebec, New Brunswick and Ontario, adding to its existing 600 stores across Quebec and Ontario.

See also:

The potential deal is touted to have been inspired by Loblaw, one of Metro’s biggest rivals, after it saw significant success with its $12.4bn acquisition of Shoppers Drug Mart back in 2013.

“The Loblaw acquisition of Shoppers, I think, inspired Metro to think twice about going beyond food and to look at pharmaceuticals and cosmetics,” said Sylvain Charlebois, Management Dean of Dalhousie University, speaking to BNN.

Jean Coutu’s shares have risen 17.3% throughout 2017 so far, whilst Metro’s have also risen, gaining 8.59% over the same period.

Share

Featured Articles

What is Nestlé CEO Laurent Freixe’s Action Plan?

Newly appointed CEO sets out action plan involving separating water brands into standalone business and boosting advertising and marketing spend

Will Mulberry Turn a New Leaf Under CEO Andrea Baldo?

International British luxury brand cuts quarter of head office staff as newly appointed CEO conducts strategic review

Female Board Members of Biggest UK Companies Paid 69% Less

Female board members of FTSE 100 companies are paid 69% less than male counterparts, as they find themselves frozen out of the biggest roles

Is This the Next CEO of LVMH?

Leadership & Strategy

How Burberry’s New CEO Is Going Back to Basics

Leadership & Strategy

Is Bayer CEO Bill Anderson Running Out of Time?

Leadership & Strategy